Bayer, Onyx: Finish Phase II study on liv. cancer drug
526806
LONDON (CBS.MW) -- Bayer Pharmaceuticals (BAY) and Onyx Pharmaceuticals (ONXX) released results from a Phase II clinical trial of BAY 43-9006 administered as a single agent in patients with advanced liver cancer.
243349
This lung cancer drug is not as effective as once hoped.
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
521918
The new Genentech, Inc., cancer drug Avastin appears to extend survival for patients with colorectal cancer by nearly two months, US National Cancer Institute researchers have concluded.
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.
588963
Bayer AG and Onyx Pharmaceutical Inc.'s  key cancer drug Nexavar significantly raises the risk of high  blood pressure, U.S. researchers said on Tuesday.
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
384412
Bristol-Myers' blood cancer drug Sprycel may work faster than Novartis' Gleevec, the once-a-day pill that transformed the treatment of some kinds of leukemia, researchers said on Saturday.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
753389
Adding the drug Avastin to a regimen of targeted therapy Erbitux and chemotherapy in patients with advanced colon cancer is more effective than the two drugs alone, a leading cancer researcher said on Wednesday.
379182
Merck KGaA's cancer drug cilengitide showed encouraging results in a Phase I study in the treatment of glioma, an aggressive form of brain tumor, the German drugs and chemicals group said on Monday.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
246773
A drug developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in some liver cancer patients in a mid-stage trial and stabilized the disease, the companies said Wednesday.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
535175
BioSante releases more info on the pivotal studies for its lead drug.
161495
Progress on its lead drug remains stalled.
726472
NEW YORK  - The use of herbal medicine is common among patients with advanced cancer who are participating in early-stage clinical trials (phase I) of experimental drugs, according to a new study.